Cheng‐Yang Chou

691 total citations
28 papers, 537 citations indexed

About

Cheng‐Yang Chou is a scholar working on Molecular Biology, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Cheng‐Yang Chou has authored 28 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Obstetrics and Gynecology and 5 papers in Surgery. Recurrent topics in Cheng‐Yang Chou's work include Uterine Myomas and Treatments (6 papers), TGF-β signaling in diseases (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). Cheng‐Yang Chou is often cited by papers focused on Uterine Myomas and Treatments (6 papers), TGF-β signaling in diseases (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). Cheng‐Yang Chou collaborates with scholars based in Taiwan, United Kingdom and United States. Cheng‐Yang Chou's co-authors include Meng‐Ru Shen, Keng‐Fu Hsu, Yi‐Hui Wu, Tzu‐Hao Chang, Chiung‐Hsin Chang, Joseph Browning, Robert J. Wilkins, J. Clive Ellory, Susan Fetzer and Shan‐Tair Wang and has published in prestigious journals such as The Journal of Physiology, Cancer Research and International Journal of Cancer.

In The Last Decade

Cheng‐Yang Chou

28 papers receiving 526 citations

Peers

Countries citing papers authored by Cheng‐Yang Chou

Since Specialization

Citations

This map shows the geographic impact of Cheng‐Yang Chou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Yang Chou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Yang Chou more than expected).

Fields of papers citing papers by Cheng‐Yang Chou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐Yang Chou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Yang Chou. The network helps show where Cheng‐Yang Chou may publish in the future.

Co-authorship network of co-authors of Cheng‐Yang Chou

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng‐Yang Chou. A scholar is included among the top collaborators of Cheng‐Yang Chou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng‐Yang Chou. Cheng‐Yang Chou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The downregulation of miR-509-3p expression by collagen type XI alpha 1-regulated hypermethylation facilitates cancer progression and chemoresistance via the DNA methyltransferase 1/Small ubiquitin-like modifier-3 axis in ovarian cancer cells 2023 ·Journal of Ovarian Research ·Yi‐Hui Wu, Yu-Fang Huang, Pei‐Ying Wu, Tzu‐Hao Chang, (unknown), Cheng‐Yang Chou	5
2	Collagen XI Alpha 1 Chain, a Novel Therapeutic Target for Cancer Treatment 2022 ·Frontiers in Oncology ·Yi‐Hui Wu, Cheng‐Yang Chou	17
3	Akt Inhibitors and COL11A1 in Epithelial Ovarian Carcinoma: A Short Note 2019 ·Cheng‐Yang Chou, Yi‐Hui Wu, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
4	SPAK mediates KCC3‐enhanced cervical cancer tumorigenesis 2014 ·FEBS Journal ·(unknown), Hsiao‐Sheng Liu, Yi‐Hui Wu, Meng‐Ru Shen, Cheng‐Yang Chou	18
5	Enzyme digestion-based microfluidic system for DNA methylation assay 2012 ·Chih‐Hung Wang, Keng‐Fu Hsu, Cheng‐Yang Chou, Gwo‐Bin Lee	1
6	Intention to Obtain Human Papillomavirus Vaccination Among Taiwanese Undergraduate Women 2009 ·Sexually Transmitted Diseases ·(unknown), Susan Fetzer, Keng‐Fu Hsu, (unknown), (unknown), Cheng‐Yang Chou	51
7	Costs of cervical cancer and precancerous lesions treatment in a publicly financed health care system 2009 ·Archives of Gynecology and Obstetrics ·Chao‐Hsiun Tang, Raoh‐Fang Pwu, (unknown), Han‐I Wang, San‐Lin You, Chi‐An Chen, Paul Scuffham, Chang‐Yao Hsieh, Cheng‐Yang Chou, (unknown), (unknown), Chien‐Jen Chen	10
8	EGF upregulates Na⁺/H⁺ exchanger NHE1 by post‐translational regulation that is important for cervical cancer cell invasiveness 2007 ·Journal of Cellular Physiology ·(unknown), Cheng‐Yang Chou, Keng‐Fu Hsu, (unknown), Meng‐Ru Shen	78
9	IGF‐1 upregulates electroneutral K‐Cl cotransporter KCC3 and KCC4 which are differentially required for breast cancer cell proliferation and invasiveness 2006 ·Journal of Cellular Physiology ·(unknown), Cheng‐Yang Chou, Helen H.W. Chen, Wen‐Ying Lee, Yih‐Fung Chen, Pin‐Wen Lin, Seth L. Alper, J. C. Ellory, Meng‐Ru Shen	36
10	Discordant responses to progestin in a patient with uterine low‐grade smooth‐muscle tumors metastatic to the lung 2005 ·Journal of obstetrics and gynaecology research ·(unknown), Huang Sc, Chung‐Liang Ho, Ching‐Cherng Tzeng, Cheng‐Yang Chou, Keng‐Fu Hsu	6
11	Myosin light chain kinase modulates hypotonicity-induced Ca2+ entry and Cl– channel activity in human cervical cancer cells 2002 ·Pflügers Archiv - European Journal of Physiology ·Meng-Ru Shen, Paola Furla, Cheng‐Yang Chou, (unknown)	25
12	Serum CA-125 in Preoperative Patients at High Risk for Endometriosis 2002 ·Obstetrics and Gynecology ·(unknown), Shan‐Tair Wang, Cheng‐Yang Chou	22
13	Oestrogen deficiency causes DNA damage in uterine leiomyoma cells: a possible mechanism for shrinkage of fibroids by GnRH agonists 2001 ·BJOG An International Journal of Obstetrics & Gynaecology ·(unknown), Cheng‐Yang Chou, Huang Sc, (unknown)	2
14	Human cervical cancer cells use Ca²⁺ signalling, protein tyrosine phosphorylation and MAP kinase in regulatory volume decrease 2001 ·The Journal of Physiology ·Meng‐Ru Shen, Cheng‐Yang Chou, Joseph Browning, Robert J. Wilkins, J. Clive Ellory	49
15	Major Complications of Operative Gynecologic Laparoscopy in Southern Taiwan 2001 ·The Journal of the American Association of Gynecologic Laparoscopists ·(unknown), (unknown), Cheng‐Yang Chou	33
16	VOLUME‐ACTIVATED TAURINE TRANSPORT IS DIFFERENTIALLY ACTIVATED IN HUMAN CERVICAL CANCER HT‐3 CELLS BUT NOT IN HUMAN PAPILLOMAVIRUS‐IMMORTALIZED Z183A AND NORMAL CERVICAL EPITHELIAL CELLS 1997 ·Clinical and Experimental Pharmacology and Physiology ·Cheng‐Yang Chou, Meng‐Ru Shen, (unknown), Ko‐En Huang	6
17	Color Doppler ultrasonography and serum CA 125 in the differentiation of benign and malignant ovarian tumors 1994 ·Journal of Clinical Ultrasound ·Cheng‐Yang Chou, Chiung‐Hsin Chang, (unknown), (unknown)	35
18	Cardiovascular collapse during gynecologic laparoscopy complicated by pulmonary edema: report of a case. 1994 ·PubMed ·Meng‐Hsing Wu, Chieh‐Chung Lin, Yi‐Ching Yang, Cheng‐Yang Chou	3
19	Serial follow‐up of abnormal flow velocity waveforms of dying fetus in a case of chronic hypertension 1993 ·Journal of Clinical Ultrasound ·Huang Sc, Chie‐Pein Chen, Fong‐Ming Chang, Cheng‐Yang Chou	2
20	Prediction of fetal macrosomia by single ultrasonic fetal biometry. 1993 ·PubMed ·(unknown), (unknown), Chiung‐Hsin Chang, Yee‐Shin Lin, Cheng‐Yang Chou, (unknown)	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact